Logotype for Privia Health Group Inc

Privia Health Group (PRVA) Q3 2024 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Privia Health Group Inc

Q3 2024 earnings summary

8 Jul, 2026

Executive summary

  • Achieved strong financial and operational performance in Q3 2024, with implemented providers up 13.1% to 4,642 and attributed lives up 14.0% to 1,247,000 year-over-year.

  • Expanded into Indiana with a new multi-specialty practice, now operating in 14 states and DC, and record new provider signings year-to-date.

  • Delivered $176.6 million in MSSP 2023 shared savings, up 34.1% from 2022, with 81% of lives in downside risk tracks.

  • Maintained high provider retention (98%+) and a Net Promoter Score of 85, serving over 5.1 million patients and 1.2 million attributed lives.

  • Net income for Q3 2024 was $3.5 million, down from $5.6 million in Q3 2023, primarily due to higher operating expenses and stock-based compensation.

Financial highlights

  • Q3 2024 revenue was $437.9 million, up 4.9% year-over-year; practice collections reached $739.9 million, up 2.3% year-over-year.

  • Adjusted EBITDA for Q3 2024 was $23.6 million (23.3% margin), up 25.8% year-over-year; care margin was $101.4 million, up 10.2%.

  • Year-to-date free cash flow was $87 million, pro forma for net CMS cash, with a pro forma cash balance of $473.5 million and no debt.

  • Adjusted net income per diluted share for Q3 2024 was $0.20, up from $0.17 in Q3 2023.

  • Gross profit for Q3 2024 was $99.9 million, up from $90.6 million in Q3 2023.

Outlook and guidance

  • Raised 2024 guidance to the high end or above for all metrics, including attributed lives above 1.2 million, practice collections of $2.875 billion, GAAP revenue of $1.675 billion, care margin of $400 million, and adjusted EBITDA of $90 million.

  • Targeting annual adjusted EBITDA growth of 20% or greater, with ~90% of full-year adjusted EBITDA expected to convert to free cash flow.

  • Confident in continued organic provider growth and operating leverage into 2025, despite ongoing headwinds in Medicare Advantage.

  • Practice collections guidance includes a $198 million year-over-year impact from renegotiated Medicare Advantage capitation agreements.

  • Management expects cash on hand and operating cash flows to be sufficient for both short- and long-term capital needs.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more